Evidence map›Paper›PMID 41294565›Full record

ArticleGels (Basel, Switzerland)2025

Update on the Research of an Emulgel for the Effective Treatment of Atopic Dermatitis: Clinical Investigation in Children.

Almudena Gómez-Farto, Ana Leticia Jiménez-Escobar, Noelia Pérez-González, Amy Lozano-White, Jésica Expósito-Herrera, Trinidad Montero-Vílchez, Beatriz Clares, Salvador Arias-Santiago

Abstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Almudena Gómez-FartoInstitute for Biotechnology, Pharmaceutical and Orphan Drug Research, S.L., 18016 Granada, Spain.ORCID 0000-0002-9084-050X
Ana Leticia Jiménez-EscobarInstitute for Biotechnology, Pharmaceutical and Orphan Drug Research, S.L., 18016 Granada, Spain.ORCID 0000-0002-4798-0822
Noelia Pérez-GonzálezInstitute for Biotechnology, Pharmaceutical and Orphan Drug Research, S.L., 18016 Granada, Spain.ORCID 0000-0001-6251-1752
Amy Lozano-WhiteHealth Centre La Chana, 18015 Granada, Spain.ORCID 0009-0005-9125-5803
Jésica Expósito-HerreraHealth Centre Cijuela, 18339 Granada, Spain.
Trinidad Montero-VílchezBiosanitary Institute of Granada, 18012 Granada, Spain.ORCID 0000-0003-4035-7955
Beatriz ClaresDepartment of Pharmacy & Pharmaceutical Technology, Faculty of Pharmacy, University of Granada, 18071 Granada, Spain.ORCID 0000-0001-6126-7890
Salvador Arias-SantiagoBiosanitary Institute of Granada, 18012 Granada, Spain.ORCID 0000-0002-4186-1435

Funding

FEDER INTERCONECTA ITC-20181113
6 · The paper itself

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin condition that affects up to 25% of children and impairs both skin barrier function and quality of life. This study examined the effectiveness of an emulgel containing hyaluronic acid, glycerol, grape seed oil,

Indexed as

atopic dermatitischildreneczemaemulgelepidermal growth factorhyaluronic acidskin barrier function

Identifiers

PMID41294565
PMCPMC12652510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.